Nearly VND 20 billion sponsored by Vingroup for research projects on response to novel coronavirus
All funding will be used by these organizations for conducting research and producing test kits for disease diagnosis; researching treatment regimens
Vingroup Innovation Foundation (VINIF) - Vingroup Big Data Institute (VINBDI) signed the sponsorship agreement for three research projects to respond quickly to the severe acute respiratory syndrome coronavirus (COVID-19) outbreak. The program aims to promote emergency measures to prevent the spread of disease, provide information to support early warning for care, treatment and protection of public health.
The units funded by Vingroup Innovation Foundation (VINIF) include The Company for Vaccine and Biological Production No.1 (Vabiotech), Pasteur Institute in Ho Chi Minh City and Institute of Preventive Medicine and Public Health.
In particular, The Company for Vaccine and Biological Production No.1 (Vabiotech) will be funded VND 8 billion for the project: "Developing vaccines against the novel coronavirus (Covid-19 on growing medium of Baculoviruses at laboratory scale" led by Dr. Do Tuan Dat.
Pasteur Institute in Ho Chi Minh City will receive a grant of nearly VND 7.5 billion for the project "Research on epidemiological characteristics and severe acute respiratory syndrome coronavirus (2019-nCoV) in Vietnam" led by Assoc. Prof. Phan Trong Lan.
Finally, Institute of Preventive Medicine and Public Health will be sponsored VND 4 billion for the project "Development of a national early warning system for the global Covid-19 epidemic outbreak to assess risk of infection and develop an emergency response plan" led by Assoc. Prof. Le Thi Huong.
All funding will be used by these organizations for conducting research and producing test kits for disease diagnosis; researching treatment regimens; research and manufacture of vaccines; research on the epidemiological characteristics, viral characteristics, transmission ability - the transmission mode of the disease to give appropriate warnings, etc.
Specifically, The Company for Vaccine and Biological Production No.1 is expected to produce 1,000 doses of novel Coronavirus (Covid-19) vaccine and work on technological process of producing coronavirus vaccine on baculovirus media at laboratory scale.
Institute of Preventive Medicine and Public Health will develop a statistical model for disease analysis, a disease forecast tool and estimate of necessary resources. Pasteur Institute in Ho Chi Minh City will study epidemiological characteristics, infection process, virus characteristics, serum response in infected people and response to the novel coronavirus epidemic in the North, the South, the Central and the Central Highlands of Vietnam; in addition to working on a model to forecast the situation and a solution to prevent epidemics.